Our Objectives

Our Objectives

LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.

Read More

Our Members

Our Members

Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.

Read More

Our Diagnosis

Our Diagnosis

Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.

Read More

28th November: Current challenges in clinical trials

Lung Cancer Europe will hold an event on 28th November at the EU Parliament to highlight the current challenges in clinical trials across Europe Within the occasion of this event, the 3rd edition of the LuCE report, which highlights some of the challenges still faced regarding research, will be presented. For the third consecutive year, LuCE will hold an event at […]

Read More

November is Lung Cancer Awareness Month

According to Globocan 2018, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths). In November all stakeholders mark the Lung Cancer Awareness Month and Lung Cancer Europe will continue to raise awareness about inequities regarding the access to lung […]

Read More

Being heard over the noise

LuCE president, Stefania Vallone provided an insight analysis on “Being heard over the noise: The patient viewpoint” during #ESMO2018. She emphasized the role can patients and patient organizations play within the new therapies development and reimbursement. According to her, in lung cancer, time matters for patient, thus early diagnosis is crucial for a good prognosis. Anyhow, with patients who do/have […]

Read More

LuCE stand at ESMO 2018

We invite all interested ESMO members to visit us @LuCE booth located in the society village at ESMO 2018 in Munich. Name: LuCE Hall: B1 Stand: PA 8 LuCE team will answer your questions and will provide materials and information about #lungcancer. Check out the map 1 and map 2 to easily find us.

Read More